| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BIOMATERIALS.2013.08.082 |
| P8608 | Fatcat ID | release_dfrbrv57azbbjouifwnsa5omfu |
| P932 | PMC publication ID | 3882008 |
| P698 | PubMed publication ID | 24060423 |
| P5875 | ResearchGate publication ID | 256983009 |
| P50 | author | Yadong Wang | Q41891369 |
| Jin Gao | Q44797754 | ||
| Kee-Won Lee | Q55643908 | ||
| P2093 | author name string | Noah R Johnson | |
| P2860 | cites work | Controlled delivery of sonic hedgehog morphogen and its potential for cardiac repair | Q27321295 |
| Structural and Functional Basis of CXCL12 (Stromal Cell-derived Factor-1 ) Binding to Heparin | Q27643703 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| A systems biology approach for the investigation of the heparin/heparan sulfate interactome | Q28308135 | ||
| Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice | Q30165266 | ||
| Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling | Q33537670 | ||
| Control growth factor release using a self-assembled [polycation:heparin] complex | Q33603057 | ||
| Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo | Q33640562 | ||
| Migration of marrow stromal cells in response to sustained release of stromal-derived factor-1alpha from poly(lactide ethylene oxide fumarate) hydrogels | Q33810547 | ||
| Functional arteries grown in vitro | Q33858809 | ||
| Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions | Q34310812 | ||
| Synergistic effects of SDF-1α chemokine and hyaluronic acid release from degradable hydrogels on directing bone marrow derived cell homing to the myocardium | Q34353023 | ||
| Decellularized tissue-engineered blood vessel as an arterial conduit | Q35021908 | ||
| Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel | Q35105356 | ||
| Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis. | Q35170697 | ||
| Elastomeric PGS scaffolds in arterial tissue engineering | Q35203133 | ||
| Type I collagen, fibrin and PuraMatrix matrices provide permissive environments for human endothelial and mesenchymal progenitor cells to form neovascular networks | Q35227477 | ||
| Fast-degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neoartery | Q36223451 | ||
| The effect of stromal cell-derived factor-1α/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration | Q36369400 | ||
| Controlled delivery of heparin-binding EGF-like growth factor yields fast and comprehensive wound healing. | Q37577373 | ||
| A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection | Q39290210 | ||
| The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response | Q39633175 | ||
| Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. | Q40778640 | ||
| Stromal-derived factor-1 alpha-loaded PLGA microspheres for stem cell recruitment | Q41966521 | ||
| Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. | Q42041659 | ||
| Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts | Q42470951 | ||
| Quantitation of CXCR4 expression in myocardial infarction using 99mTc-labeled SDF-1alpha | Q42543638 | ||
| Macroporous elastomeric scaffolds with extensive micropores for soft tissue engineering. | Q42802540 | ||
| A tough biodegradable elastomer | Q42814492 | ||
| Successful application of tissue engineered vascular autografts: clinical experience | Q44181125 | ||
| The effect of a heparin-based coacervate of fibroblast growth factor-2 on scarring in the infarcted myocardium | Q45340551 | ||
| Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells | Q46533885 | ||
| A [polycation:heparin] complex releases growth factors with enhanced bioactivity | Q50440131 | ||
| Cell guidance in tissue engineering: SDF-1 mediates site-directed homing of mesenchymal stem cells within three-dimensional polycaprolactone scaffolds. | Q50878345 | ||
| In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. | Q51059546 | ||
| Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. | Q51604860 | ||
| Sustained delivery of SDF-1α from heparin-based hydrogels to attract circulating pro-angiogenic cells. | Q53175407 | ||
| A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow | Q57601743 | ||
| A blood vessel model constructed from collagen and cultured vascular cells | Q69983909 | ||
| Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization | Q73106062 | ||
| A completely biological tissue-engineered human blood vessel | Q74075096 | ||
| Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4 | Q77952550 | ||
| The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities | Q80065296 | ||
| SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells | Q80396461 | ||
| Controlled release of stromal-cell-derived factor-1 from gelatin hydrogels enhances angiogenesis | Q82360234 | ||
| Mobilization of mesenchymal stem cells by stromal cell-derived factor-1 released from chitosan/tripolyphosphate/fucoidan nanoparticles | Q83140016 | ||
| Readily available tissue-engineered vascular grafts | Q83356711 | ||
| Improved endothelialization and reduced thrombosis by coating a synthetic vascular graft with fibronectin and stem cell homing factor SDF-1α | Q85027875 | ||
| Combined systemic and local delivery of stem cell inducing/recruiting factors for in situ tissue regeneration | Q85030674 | ||
| P433 | issue | 38 | |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 9877-9885 | |
| P577 | publication date | 2013-09-20 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Human progenitor cell recruitment via SDF-1α coacervate-laden PGS vascular grafts | |
| P478 | volume | 34 |
| Q50992929 | A single injection of protein-loaded coacervate-gel significantly improves cardiac function post infarction. |
| Q91451981 | Altered processing enhances the efficacy of small-diameter silk fibroin vascular grafts |
| Q89672482 | Artificial small-diameter blood vessels: materials, fabrication, surface modification, mechanical properties, and bioactive functionalities |
| Q26782026 | Capture of endothelial cells under flow using immobilized vascular endothelial growth factor |
| Q53219891 | Coacervate delivery of HB-EGF accelerates healing of type 2 diabetic wounds. |
| Q26860968 | Coacervate delivery systems for proteins and small molecule drugs |
| Q36198993 | Controlled dual delivery of fibroblast growth factor-2 and Interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair |
| Q33858027 | Delivery of stromal cell-derived factor 1α for in situ tissue regeneration |
| Q39477787 | Differences in the performance of PCL-based vascular grafts as abdominal aorta substitutes in healthy and diabetic rats |
| Q38346534 | Drug delivery systems for wound healing |
| Q41891314 | Dual delivery of vascular endothelial growth factor and hepatocyte growth factor coacervate displays strong angiogenic effects |
| Q64898616 | Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications. |
| Q90835368 | Endothelialization of arterial vascular grafts by circulating monocytes |
| Q38951940 | Evaluation of late outgrowth endothelial progenitor cell and umbilical vein endothelial cell responses to thromboresistant collagen-mimetic hydrogels. |
| Q35533540 | In-situ formation of growth-factor-loaded coacervate microparticle-embedded hydrogels for directing encapsulated stem cell fate. |
| Q38916341 | Materials and surface modification for tissue engineered vascular scaffolds |
| Q38751355 | Microwave-assisted facile fabrication of porous poly (glycerol sebacate) scaffolds |
| Q91962747 | Polyglycerol Hyperbranched Polyesters: Synthesis, Properties and Pharmaceutical and Biomedical Applications |
| Q92920986 | Reversing the Tumor Target: Establishment of a Tumor Trap |
| Q35602789 | Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction |
| Q39452218 | Strategies to develop endogenous stem cell-recruiting bioactive materials for tissue repair and regeneration. |
| Q47192672 | Surface functionalization of electrospun scaffolds using recombinant human decorin attracts circulating endothelial progenitor cells |
| Q38817609 | Tissue engineered vascular grafts: current state of the field. |
| Q95522401 | [Research process of the preparation of electrostatic spinning of poly-glycerol sebacate and the application in tissue engineering] |
Search more.